News
A large, well-capitalized peer is apparently interested in a partnership deal with the company. The media outlet in question ...
Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on ...
Alongside her husband, Bob Duggan, Maky Zanganeh has guided cancer drug developer Summit Therapeutics to reach staggering new ...
Second, SoFi could grow its revenue even without expanding its membership base, by cross-selling additional products to its ...
Summit Therapeutics (NASDAQ:SMMT – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a note issued ...
Zacks Investment Research on MSN3d
Wall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to TradeShares of Summit Therapeutics PLC (SMMT) have gained 2.8% over the past four weeks to close the last trading session at $21.2 ...
Revolution Medicines and Summit Therapeutics entered into a clinical collaboration in multiple solid-tumor settings to evaluate their respective treatments in combination with each other. Redwood ...
OpRegen is a suspension of embryonic stem cell-derived RPE cells restoring visual function in degenerative retinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback